Logos Global Management LP is 10% Owner at Novus Therapeutics, Inc. (NVUS). They have made 4 open-market trades across 3 companies since 2020, most recently 2021-06-21.
CIK 0001792126
3 open-market purchases totalling $23.2M since 2020, against 1 sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.